Infographics

EKG in Acute Pulmonary Embolism

EKG in Acute Pulmonary Embolism Summary: This infographic explores the EKG findings associated with acute pulmonary embolism (PE). While EKG is not a diagnostic tool for PE due to low sensitivity and specificity, it can offer supporting evidence and aid in evaluating other causes of cardiopulmonary symptoms. The mechanisms for…

Continue ReadingEKG in Acute Pulmonary Embolism

Coronary Embolus, PFO, and PAH

Coronary Embolus, PFO, and PAH This infographic reviews key points on coronary embolus, patent foramen ovale (PFO), PFO/ASD closure in pulmonary hypertension (PH), defining PH, and the vasodilator challenge. It covers the etiology of coronary emboli, indications for PFO closure, considerations for PFO/ASD closure in severe PH, and definitions and…

Continue ReadingCoronary Embolus, PFO, and PAH

Treatment of Chronic Thromboembolic Disease

Treatment of Chronic Thromboembolic Disease This infographic outlines the treatment approach for Chronic Thromboembolic Pulmonary Hypertension (CTEPH). It begins with the confirmation of CTEPH diagnosis and lifelong anticoagulation, followed by the assessment of operability for pulmonary endarterectomy. Treatment options are divided based on operability, including pulmonary endarterectomy, targeted medical therapy,…

Continue ReadingTreatment of Chronic Thromboembolic Disease

CTEPH and May-Thurner Syndrome

CTEPH and May-Thurner Syndrome This infographic provides an overview of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and May-Thurner Syndrome. It includes key diagnostic criteria, echo findings related to pulmonary hypertension, arrhythmias associated with CTEPH, and the steps for defining and treating CTEPH. Emphasis is placed on the importance of a high…

Continue ReadingCTEPH and May-Thurner Syndrome

Cardio-Oncology: 2022 AHA/ACC/HFSA Heart Failure Guidelines

Cardio-Oncology: 2022 AHA/ACC/HFSA Heart Failure Guidelines This infographic highlights the significance of identifying and monitoring cancer therapy-related cardiotoxicity (CTRC). It emphasizes a multidisciplinary, patient-centered approach to managing oncological therapies to mitigate the risks of cardiac dysfunction. Recommendations are provided for both pretherapy and ongoing cardiac monitoring, particularly for patients with…

Continue ReadingCardio-Oncology: 2022 AHA/ACC/HFSA Heart Failure Guidelines

Cardiac Manifestations of Systemic Sclerosis

Cardiac Manifestations of Systemic Sclerosis (SSc) This infographic explores the cardiac involvement in systemic sclerosis (SSc), a chronic autoimmune disease characterized by skin thickening, vasculopathy, internal organ fibrosis, and autoantibodies. Cardiac involvement is often subtle but can have significant morbidity and mortality. Key Points Often Underdiagnosed: Up to 70% of…

Continue ReadingCardiac Manifestations of Systemic Sclerosis

End of content

No more pages to load